GPR17 and glioblastoma: Higher GPR17 expression is associated with better prognosis in patients with low-grade gliomas, according to the Chinese Glioma Genome Atlas (CGGA) [319] and GEPIA [9], but the expression of this receptor is not associated with prognosis in a GBM patient [9].